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A b strac t  A  patient with neonatal 
expression of severe De Toni-Debré- 
Fanconi syndrome is presented. B e­
cause of early signs of renal tubu- 
lopathy together with a large urinary 
excretion of lactate, 3-hydroxybu- 
tyrate and citric acid cycle intermedi­
ates, a mitochondrial disorder was 
suspected and muscle and liver b iop­
sies were performed. Biochemical 
investigations in both tissues re­
vealed a defect in the respiratory 
chain at the level o f  complex III. In 
this patient renal dysfunction was the
primary symptom, and hyperlac- 
tataemia, an important clue for a m i­
tochondrial disorder, was lacking.
C onclus ion  Com plex III defi­
ciency should be included in the 
differential diagnosis o f  neonatal 
D e Toni-Debré-Fanconi syndrome.
K ey w o rd s  De Toni-Debré-Fanconi 
syndrom e • Respiratory chain 
defects ■ Complex III
A b b rev ia t io n  ATP  adenosine 
triphosphate
Introduction
The renal tubulopathy De Toni-Debré-Fanconi syndrome 
is seen in different disorders of the mitochondiial respira­
tory chain with impaired adenosine triphosphate (ATP) 
production required for proper renal tubular transport ac­
tivity (Fig. 1). It is relatively common in fatal infantile 
myopathy due to cytochrome c oxidase (complex IV) de­
ficiency [2, 9, 15] and has also been reported as a feature 
o f  complex I and combined complex III/IV deficiencies 
[6 , 7, 11]. Moreover, De Toni-Debré-Fanconi syndrome is 
invariably involved at a late stage of Pearson syndrome, a 
mitochondrial disorder with a mitochondrial DNA dele­
tion affecting different organs including the kidneys [4, 8, 
10, 13]. Here we report the neonatal expression of severe 
renal tubulopathy associated with complex III deficiency 
o f  the respiratory chain in muscle and liver.
Case report
A 2-month-old baby was admitted to the hospital because of fail­
ure to thrive. He was born by normal delivery after an uncompli­
cated 42-week pregnancy. Birth weight was 2.5 kg, length was 48 
cm, He was the fourth child of a consanguineous Turkish couple. 
Family history was unremarkable.
On admission the child presented with a mild upper respiratory 
tract infection, laryngeal stridor due to tracheomalacia, hyper- 
pnoea, wide open fontanelles and sutures, rickets, irritability, mus­
cle weakness and insufficient response to stimuli. He was mildly 
dehydrated; weight was 3.0 kg. Laboratory tests showed metabolic 
acidosis (pH 7.28, bicarbonate 15 mEq/1, base excess -  1 1 ) with 
otherwise normal serum electrolytes, glucose and creatinine. 
Transaminases (about 150 U/l) and alkaline phosphatase (1250 
U/l) were elevated. The latter indicated active rickets, Inorganic 
phosphate (0.46 mmol/I and 1.4 mg/dl) and uric acid (53 pmol/1 
and 0.89 mg/dl) were decreased. Serum triglycerides (3.3 mmol/1 
and 2.92 mg/dl) were moderately elevated. Blood lactate (1.7—2.9; 
normal < 2.0 mmol/I) and pyruvate (0.077; normal < 0.065 
mmol/1) concentrations were normal or mildly elevated. Serum 
amino acids, including alanine, were normal. The urinary hype rex - 
cretion of  amino acids o f  all classes, glucose, bicarbonate and 
phosphate indicated proximal tubulopathy.
At the age of 4 months biochemical investigation also included 
the analysis of urinary organic acids. There were markedly in-
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Fig-1 Schematic presentation 
of the mitochondrial respira­
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Table 1 Urinary organic acid and alanine excretion (mmol/mol 
creatinine) in our patient, in a 15-month-old child with cystinosis, 






Lactate 28,500 800 150 < 2 0 0
3-Hydroxy-
butyrate
25,000 5,400 35 A 00 o
Fumarate 260 45 1 < 2 0
Malate 1 0 2 0 1 2 0 3 < 50
Succinate 850 0 25 < 150
Alanine 1 2 , 0 2 0 850 500 < 160
creased amounts of lactate and 3-hydroxybutyrate (Table 1) to­
gether with a complex pattern of organic acids (fumarate, succi­
nate, and mal ate), suggestive of a respiratory chain defect. In CSF, 
lactate and amino acid concentrations were normal. Serum total 
and free carnitine levels were also normal.
From the age of 4 months the patient was treated symptomati­
cally with bicarbonate, phosphate supplements, 1,25-dihydroxy- 
cholecalciferol, and carnitine. Later he also received vitamin K (40 
mg/day) and riboflavin (100 mg/day). However, his clinical condi­
tion deteriorated and the child died of respiratory distress at the age 
of 7 months. No autopsy was performed and no post mortem kid­
ney tissue was available.
Methods
Because of the early occurring De Toni-Debré-Fanconi syndrome 
and massive urinary excretion of lactate, a mitochondrial disorder 
was suspected. In order to obtain mitochondrial material for bio­
chemical and morphological investigations a surgical muscle 
biopsy of the quadriceps and a needle biopsy of the liver were per­
formed.
Substrate oxidation rates, ATP production rates, mitochondrial 
enzyme activities and carnitine content were measured in 600 g 
supernatants of muscle homogenatcs as described previously [3, 
12]. Complex III activity was measured using decylubiquinol as a 
substrate according to Zheng et al. [16] with modifications. Light 
microscopy, histochemical and histo-enzymological stainings 
were done according to standard procedures. Mitochondrial DNA 
was analysed as reported earlier [1]. Other laboratory investiga­
tions were performed according to routine procedures.
Results
Biochemical investigation in fresh skeletal muscle super­
natant revealed that oxidation rates with pyruvate, malate 
and succinate as substrates and ATP+creatine phosphate 
production rates with pyruvate and malate were both se­
verely diminished (< 20% of lowest control values). These 
data, as well as the activities of the respiratory chain sub­
units in muscle and liver and carnitine concentration in 
muscle, are listed in Table 2. Due to the small amount of 
liver tissue, only few activities could be measured. Table 
2 shows that complex III activity was most severely de­
creased (in muscle 13% of the lowest control value). The 
activities o f  succinate: cytochrome c oxidoreductase and 
NADH: 0 2 oxidoreductase, which both measure also 
complex III activity [14], were less reduced (50% of the 
lowest control values). These values point to a severe de­
ficiency of complex III o f  the respiratory chain. A com­
plex III deficiency (59% of the lowest control value) was 
also found in the liver. Carnitine concentration (total and 
free) was reduced in muscle.
Histopathological findings in muscle revealed a nor­
mal libre structure with an increased lipid content in type 
I fibres. Ragged red fibres were not seen. On electron mi­
croscopy there were no structural abnormalities of the mi-
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Table 2 Biochemical parame­
ters of muscle and liver tissue
a nmoles* hr- 1  - mg - 1  protein 
b mU • mg" 1 protein 




[1 - ,4 C] pyruvate + malate 56 2 7 3 - 7 0 5 (n = 19)
[U - 14C] malate + pyruvate + malonate 38 3 2 0 - 9 9 6 (n = 19)
ATP +  creatine phosphate production rate11 from
pyruvate + malate 535 1 8 3 3 -8 0 7 5  (n =  25)
succinate + acetylcarnitine 142 8 1 4 -1 5 2 7 in = 7)
Activity11 of
citrate synthase 45 4 8 - 1 6 2 (n =  32)
cytochrome c oxidase 54 6 8 -4 3 7 (n =  54)
succinate: cytochrome c oxidoreductase 11 2 2 - 8 9 (n =  35)
decylubiquinol: cytochrome c oxidoreductasSe 32 2 5 3 - 6 1 9 (n =  1 0 )
NADH: Qj oxidoreductase 5.3 4 .4 -2 5 .9 (n =  28)
NADH: Oi oxidoreductase 12 2 4 - 8 7 (.n = 9)
pyruvate dehydrogenase complex 4.4 2 ,7 -8 .2 (n = 15)
Concentration1'' of
carnitine, total 1.6 2 . 7 - 4 .6 (n = 2 1 )
carnitine, non esterified 1.2 2 ,2 -4 .2 (n =  2 1 )
creatine, total 2 0 1 5 -3 6 {n =  9)
Liver
Cytochrome c oxidase“ 71 3 7 -5 3 (n =  4)
Succinate cytochrome oxidoreductase 3.1 6 .0 -5 1 (n =  4)
Decylubiquinol: cytochrome c oxidoreductase 4J 6 9 -1 0 7 (n = 4)
tochonclria. Some muscle fibres contained fat vacuoles 
close to the mitochondria. Liver morphology was without 
specific abnormalities. No mitochondrial DNA deletions 
or frequently occurring mutations were found.
Discussion
We describe a patient in whom onset of severe De Toni- 
Debré-Fanconi syndrome in early infancy lead us above 
all to look for a biochemical defect at the level of mito­
chondrial oxidative phosphorylation. This was done under 
the assumption that the energy requiring process of renal 
tubular transport might be severely disturbed due to a fail­
ure of the respiratory chain to produce adequate amounts 
o f  ATP. Since kidney tissue could not be obtained for bio­
chemical investigations, we strived to demonstrate the as­
sumed respiratory chain defect in other organs such as 
muscle and liver. In both tissues a severely decreased ac­
tivity of complex III of the respiratory chain was found 
giving rise to a significantly impaired oxidative phospho­
rylation in whole mitochondria.
Usually, patients suspected of having a mitochondrial 
disorder are selected after demonstration of elevated lac­
tate concentrations in blood and/or CSF, Due to the ab­
sence of evidently increased lactate concentrations in both 
body fluids, a defect in the respiratory chain could have 
been overlooked in our patient. It might be possible that
the high renal clearance of lactate (daily loss: 14-20 
mmoles) caused by the disrupted tubular reabsorption was 
responsible for the almost normal lactate levels. Interest­
ingly, another case o f  severe respiratory chain defect in 
muscle (deficient cytochrom e-c-oxidase activity) and De 
Toni-Debré-Fanconi syndrome also with absence o f  se­
verely elevated blood lactate levels has been reported [9]. 
However, with respect to the extreme amounts of urinary 
lactate, 3-hydroxybutyrate, and other organic acids, as 
compared with other patients with a serious form  of tubu­
lopathy due to cystinosis or ifosfamide toxicity (Table 1), 
it seems that part o f  these metabolites originates also from 
high production in the kidney itself. A ccording to earlier 
reports [4, 13] an increased production and excretion of 
lactate and particularly of intermediates of the citric acid 
cycle was explicitly attributed to tubulopathy due to m ito­
chondrial disorders.
The block at the com plex III level impairs oxidation of 
both N A D-linked and FAD-linked substrates (Fig. 1). In 
most previous publications the diagnosis of complex III 
(ubiquinol:cytochrome c oxidoreductase) deficiency was 
concluded indirectly from a  reduced activity for both suc- 
cinatexytochrom e c oxidoreductase and rotenone-sensi- 
tive NADH: 0 2 oxidoreductase and a normal activity of 
succinate dehydrogenase [5, 14]. In our patient complex 
III activity was measured directly by a spectropho tome trie 
assay, using decylubiquinol as a substrate. This activity 
was severely reduced in skeletal muscle and liver. The re­
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duced rate of pyruvate, malate, and succinate oxidation, as 
well as of ATP production in fresh muscle suggest that the 
overall respiratory chain activity in vivo was significantly 
impaired by the complex III deficiency. The low muscle 
carnitine concentration is a secondary phenomenon which 
is frequently found in respiratory chain disorders.
Complex III deficiency is a relatively rare type of m i­
tochondrial disorder. Moreover, among the small number 
of patients (ca. 20) described with a defect of complex III 
there is great variability in the clinical presentation, in­
cluding tissue specific defects such as pure skeletal m us­
cle disease and pure fatal cardiomyopathy, as well as pro­
gressive encephalopathy [5]. A severe complex III defi­
ciency in muscle and liver could recently also be demon­
strated in tissues (stored at -80°C ) from the neonate with 
severe lactic acidosis and renal tubulopathy, described by 
Sperl et al, [11] by using decylubiquinol as a substrate in 
the measurement of complex III activity (residual activity 
16% of the lowest control value). Thus, the present and 
the previously reported case expand the clinical spectrum 
o f  complex III defect to include neonatal expression of se­
vere renal tubulopathy.
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